Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Research groups

Collaborators

James Lambton

PhD


Postdoctoral Research Scientist

I have joined the Wade-Martins lab as part of the Oxford-GSK IMCM looking at sporadic Parkinson’s disease. We aim to use iPSC derived dopaminergic neuron and co-cultures from sporadic patients with varying phenotypes to identify common disease mechanisms. Identification of common disease mechanisms in sporadic Parkinson’s should aide in novel therapeutic targets for patients with no identified genetic cause. I previously completed my PhD at Newcastle University where I focused congenital disorders of autophagy and the resulting neurological disease. This involved generating iPSC derived neural models of patients harbouring variants in core autophagy genes. Alongside my iPSC work, I characterised a number of novel autophagy related disease genes using a variety of patient tissues to better our understand cellular homeostasis in the absence of autophagy.